- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Clears AI 'Contouring Assistant' in MRI-Guided Ultrasound Ablation Procedures
The artificial intelligence (AI)-powered module provides a prostate segmentation tool for MRI-guided transurethral ultrasound ablation (TULSA) procedures in patients with prostate cancer.
Reportedly built on over 24 million parameters drawn from nearly 7,500 training images, the artificial intelligence (AI) module Contouring Assistant has garnered 510(k) clearance from the Food and Drug Administration (FDA) for use in MRI-guided transurethral ultrasound ablation (TULSA) procedures in patients with prostate cancer.
Utilized in conjunction with Profound Medical’s TULSA-PRO system, the Contouring Assistant module offers machine learning-based segmentation of the prostate to facilitate targeted ablation of diseased tissue.
Utilized in conjunction with Profound Medical’s TULSA-PRO system (shown above), the recently FDA-cleared Contouring Assistant module provides machine-learning based prostate segmentation, which was found to be non-inferior to contouring done by leading prostate radiologists, according to Profound Medical, the manufacturer of the Contouring Assistant module. (Image courtesy of Profound Medical.)
Profound Medical noted that the Contouring Assistant module was developed with a reference standard that combined contours from leading prostate radiologists Steven Raman, M.D., Robert Princethal, M.D., and Edward Steiner, M.D. Subsequent research evaluating the stand-alone capability of Contouring Assistant in 100 prostate cancer cases found it was non-inferior to the aforementioned reference standard, according to Profound Medical.
The company also noted that additional testing of the Contouring Assistant module by three urologists demonstrated a 32 percent reduction in the time it took to complete prostate segmentation.
“ … (Contouring) Assistant not only allowed my esteemed urologist colleagues and I to approach the accuracy of an expert radiologist reader in our TULSA treatment designs, but also enabled us to reduce overall procedure times by one-third,” noted Preston Sprenkle, M.D., an associate professor of urology at the Yale School of Medicine in New Haven, Ct.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
